Literature DB >> 11011143

Kinetic basis for the donor nucleotide-sugar specificity of beta1, 4-N-acetylglucosaminyltransferase III.

Y Ikeda1, S Koyota, H Ihara, Y Yamaguchi, H Korekane, T Tsuda, K Sasai, N Taniguchi.   

Abstract

The kinetic basis of the donor substrate specificity of beta1, 4-N-acetylglucosaminyltransferase III (GnT-III) was investigated using a purified recombinant enzyme. The enzyme also transfers GalNAc and Glc moieties from their respective UDP-sugars to an acceptor at rates of 0.1-0.2% of that for GlcNAc, but Gal is not transferred at a detectable rate. Kinetic analyses revealed that these inefficient transfers, which are associated with the specificity of the enzyme, are due to the much lower V(max) values, whereas the K(m) values for UDP-GalNAc and UDP-Glc differ only slightly from that for UDP-GlcNAc. It was also found that various other nucleotide-Glc derivatives bind to the enzyme with comparable affinities to those of UDP-GlcNAc and UDP-Glc, although the derivatives do not serve as glycosyl donors. Thus, GnT-III does not appear to distinguish UDP-GlcNAc from other structurally similar nucleotide-sugars by specific binding in the ground state. These findings suggest that the specificity of GnT-III toward the nucleotide-sugar is determined during the catalytic process. This type of specificity may be efficient in preventing a possible mistransfer when other nucleotide-sugars are present in excess over the true donor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011143     DOI: 10.1093/oxfordjournals.jbchem.a022793

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.

Authors:  Suguru Oguri; Aruto Yoshida; Mari T Minowa; Makoto Takeuchi
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

2.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

3.  Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO.

Authors:  Deug-Nam Kwon; Hyuk Song; Jong-Yi Park; So-Young Lee; Seong-Keon Cho; Sung-Jo Kang; Joung Soon Jang; Han Geuk Seo; Jin-Hoi Kim
Journal:  Transgenic Res       Date:  2006-02       Impact factor: 2.788

4.  UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase.

Authors:  Liang Ma; Omar Salas; Kyle Bowler; Maor Bar-Peled; Amir Sharon
Journal:  MBio       Date:  2017-11-21       Impact factor: 7.867

5.  Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.

Authors:  Ken Hanzawa; Miki Tanaka-Okamoto; Hiroko Murakami; Noriko Suzuki; Mikio Mukai; Hidenori Takahashi; Takeshi Omori; Kenji Ikezawa; Kazuyoshi Ohkawa; Masayuki Ohue; Shunji Natsuka; Yasuhide Miyamoto
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.